Stem Cell Autograft Minimal Residual Disease Negativity Improves Outcomes after Autotransplant for Multiple Myeloma

被引：1

作者：

Nishimura, Noriko ^{[1
]}

Brown, Samantha ^{[2
]}

Devlin, Sean M. ^{[3
]}

Dahi, Parastoo B. ^{[4
,5
]}

Landau, Heather ^{[4
,6
]}

Lahoud, Oscar B. ^{[6
]}

Scordo, Michael ^{[4
,6
]}

Shah, Gunjan L. ^{[4
,7
]}

Hassoun, Hani ^{[8
]}

Hultcrantz, Malin ^{[8
]}

Korde, Neha ^{[8
]}

Lesokhin, Alexander M. ^{[5
,9
]}

Mailankody, Sham ^{[5
]}

Shah, Urvi A. ^{[8
]}

Tan, Carlyn ^{[8
]}

Usmani, Saad ^{[10
]}

Giralt, Sergio A. ^{[4
,11
]}

Chung, David J. ^{[4
,6
]}

Gupta, Gaurav ^{[12
]}

Maryamchik, Elena ^{[12
]}

Ntrivalas, Evangelos ^{[13
]}

Roshal, Mikhail ^{[14
]}

机构：

[1] Sloan Kettering Inst Canc Res, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol Biostat, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA

[4] Weill Cornell Med Coll, Dept Med, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[7] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, Cellular Therapy Serv, 1275 York Ave, New York, NY 10021 USA

[8] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[9] Weill Cornell Med Coll, New York, NY USA

[10] Levine Canc Inst, New York, NY USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplantat Serv, 1275 York Ave, New York, NY 10021 USA

[12] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Transfus Med & Cell Therapy, 1275 York Ave, New York, NY 10021 USA

[13] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Cellular Immunol Serv, 1275 York Ave, New York, NY 10021 USA

[14] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, 1275 York Ave, New York, NY 10021 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-160271

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Ixazomib Maintenance after autograft stem cell transplantation in multiple myeloma
Stocker, Nicolas
HEMATOLOGIE, 2019, 25 (02): : 64 - 65
[22] MINIMAL RESIDUAL DISEASE AFTER BMT FOR MULTIPLE-MYELOMA
BIRD, JM
SAMSON, D
RUSSELL, NH
BLOOD, 1993, 82 (10) : A199 - A199
[23] Minimal Residual Disease in Multiple Myeloma
Munshi, Nikhil C.
Anderson, Kenneth C.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2523 - 2526
[24] Minimal residual disease for multiple myeloma
Avet-Loiseau, Herve
Corre, Jill
HEMATOLOGIE, 2019, 25 : 36 - 39
[25] Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma
Keruakous, Amany R.
Asch, Adam
Aljumaily, Raid
Zhao, Daniel
Yuen, Carrie
TRANSPLANT IMMUNOLOGY, 2022, 71
[26] Minimal residual disease in multiple myeloma
Moukalled, Nour
Malard, Florent
Bazarbachi, Ali
Mohty, Mohamad
PRESSE MEDICALE, 2025, 54 (01):
[27] Minimal residual disease and stem cell transplantation outcomes
Cloos, Jacqueline
Ossenkoppele, Gert J.
Dillon, Richard
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 617 - 625
[28] Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
Perrot, Aurore
Lauwers-Cances, Valerie
Corre, Jill
Robillard, Nelly
Hulin, Cyrille
Chretien, Marie-Lorraine
Dejoie, Thomas
Maheo, Sabrina
Stoppa, Anne-Marie
Pegourie, Brigitte
Karlin, Lionel
Garderet, Laurent
Arnulf, Bertrand
Doyen, Chantal
Meuleman, Nathalie
Royer, Bruno
Eveillard, Jean-Richard
Benboubker, Lotfi
Dib, Mamoun
Decaux, Olivier
Jaccard, Arnaud
Belhadj, Karim
Brechignac, Sabine
Kolb, Brigitte
Fohrer, Cecile
Mohty, Mohamad
Macro, Margaret
Richardson, Paul G.
Carlton, Victoria
Moorhead, Martin
Willis, Tom
Faham, Malek
Anderson, Kenneth C.
Harousseau, Jean-Luc
Leleu, Xavier
Facon, Thierry
Moreau, Philippe
Attal, Michel
Avet-Loiseau, Herve
Munshi, Nikhil
BLOOD, 2018, 132 (23) : 2456 - 2464
[29] Minimal Residual Disease Negativity Is a New End Point of Myeloma Therapy
Harousseau, Jean-Luc
Avet-Loiseau, Herve
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (25) : 2863 - +
[30] Impact of minimal residual disease detection after treatment of multiple myeloma
Szendrei Tamas
Plander Mark
Szabo Zsuzsanna
Kereskai Laszlo
Kajtar Bela
Papp Gergely
Ivanyi Janos Laszlo
ORVOSI HETILAP, 2019, 160 (13) : 502 - 508

← 1 2 3 4 5 →